Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
European Journal of Haematology|March 23, 2011
Therapy-related myelodysplasia in a patient with Rothmund-Thomson syndromeAaron M Carlson, Noralane M Lindor, Mark R Litzow
American Journal of Medical Genetics. Part A|July 24, 2012
Chronic tibial nonunion in a Rothmund-Thomson syndrome patientAaron M Carlson, Kristen B Thomas, Salman Kirmani, et al.
Anatomical Sciences Education|May 30, 2013
A prospective, randomized crossover study comparing direct inspection by light microscopy versus projected images for teaching of hematopathology to medical studentsAaron M Carlson, Ellen D McPhail, Vilmarie Rodriguez, et al.
Annals of Clinical and Translational Neurology|April 24, 2024
Shifting patterns of multiple sclerosis treatment in a highly prevalent United States populationSue Kwon, Stefan Sillau, John R Corboy, et al.
Medical Science Educator|May 25, 2026
Reviving the Sciences: a Post-clerkship Approach to Required Basic Science EducationChad R Stickrath, Tai M Lockspeiser, Aaron M Carlson, et al.
Multiple Sclerosis and Related Disorders|December 28, 2019
A case of GFAP-astroglial autoimmunity presenting with reversible parkinsonismAnna Tomczak, Elaine Su, Madina Tugizova, et al.
Journal of Neurology|September 30, 2020
Five men with arresting and relapsing cerebral adrenoleukodystrophyAaron M Carlson, Irene C Huffnagel, Aad Verrips, et al.
Multiple Sclerosis and Related Disorders|April 11, 2022
Prevalence of multiple sclerosis and treatment utilization in a large, highly diverse populationAaron M Carlson, Carlos Vervloet Sollero, Kavita V Nair, et al.
Journal of Neurochemistry|June 16, 2009
Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulinDorothee Dormann, Anja Capell, Aaron M Carlson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 24, 2013
Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancerAaron M Carlson, Matthew J Maurer, Krista M Goergen, et al.
Pageof 2